awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44253853-98BC503D-9304-4137-B11F-0E998D7F136D
Q44253853-98BC503D-9304-4137-B11F-0E998D7F136D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44253853-98BC503D-9304-4137-B11F-0E998D7F136D
Changes in utilization and costs for patients with rheumatoid arthritis, 1997 to 2006.
P2860
Q44253853-98BC503D-9304-4137-B11F-0E998D7F136D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44253853-98BC503D-9304-4137-B11F-0E998D7F136D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd4ba56a8110e3e47e9998e83a4615bbdd8c8d1c
P2860
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.